Mike Coppinger reports that WBC super lightweight champion Subriel Matias, less than two months away from what would almost ...

The latest update is out from AnaptysBio ( (ANAB) ).

The 8 th Annual Evercore Healthcare Conference Format: Fireside Chat Host: Jonathan Miller Date and Time: Tuesday, December 2, 2025; 4:15 pm - 4:35 PM EST. Location: Sevilla A, Track 2, the Loews ...

(Nasdaq: ANAB), a clinical-stage biotechnology company focused on delivering innovative immunology therapeutics, today announced that its Board of Directors has authorized an amended Stock Repurchase ...

CF602 is a novel A3AR allosteric modulator that enhances the receptor activity in the presence of the native ligand. The ...

A comprehensive narrative review published in Translational Exercise Biomedicine, (ISSN: 2942-6812), an official partner ...

Resurrection were left with a key mystery as the first season drew to a close. Who is the New York Ripper? The serial killer ...

For those who don’t benefit from modulators, the fight against CF can feel isolating and uncertain. Five members of our community share how they’ve transformed their personal struggles into purpose — ...

Members of the Equillium management team will be available to participate in meetings with investors who are registered to attend the conference. Investors are invited to review the company corporate ...

As Neuphoria Therapeutics considers its options in the wake of the failure of its phase 3 social anxiety program, an ...

An update from Can-Fite BioPharma ( ($CANF) ) is now available. On November 20, 2025, Can-Fite BioPharma Ltd. announced that its erectile ...

Pediatric patients with cystic fibrosis starting triple combination therapy had larger relative improvements in 129Xenon MRI ...